These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4256155)

  • 1. [Blood fibrinolytic potential during acute myocardial infarction].
    Courbier R; Jausseran JM; Forlot P; Torresani J; Henry E; Jouve A
    Presse Med (1893); 1971 Oct; 79(41):1789-92. PubMed ID: 4256155
    [No Abstract]   [Full Text] [Related]  

  • 2. [The fibrinolytic system in dysfunctional pathology of the thyroid gland].
    Dettori AG; Dallavalle L; Debiasi D; Colla G
    Haematologica; 1966; 51(12):1037-58. PubMed ID: 4231362
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheological and clotting changes in the immediate post-myocardial infarction period.
    Patrassi GM; Brunetti A; de Zio A; Gribaldo A; Cafiero F; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):140-9. PubMed ID: 6164609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the blood fibrinolytic enzyme system following acute myocardial infarction.
    Bennett NB; Ogston CM; Ogston D
    Clin Sci; 1967 Feb; 32(1):27-37. PubMed ID: 4225389
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of lytic potential in the control of pre- and post-operative coagulation].
    Courbier R; Vairel E; Brunel-Atlan F
    Mars Med; 1970; 107(2):137-9. PubMed ID: 4246514
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anticoagulant therapy with "regulated hypocoagulation of the blood" in the initial period of myocardial infarct].
    Gritsiuk AI; Petrus' VG
    Kardiologiia; 1974 Nov; 14(11):31-40. PubMed ID: 4279310
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nonenzymatic fibrinolysis in patients with ischemic heart disease].
    Panchenko VM; Liapina LA
    Kardiologiia; 1974 Nov; 14(11):14-8. PubMed ID: 4279308
    [No Abstract]   [Full Text] [Related]  

  • 8. [Increase of fibrinolytic activity and reduction of platelet adhesiveness caused by prolonged treatment with ethyl-chloro-phenoxy-isobutyrate].
    Frandoli G; Gibelli A; Giarola P
    Clin Ter; 1966 Jul; 38(1):27-38. PubMed ID: 4230052
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of fibrinolysin with heparin and thrombolytin on blood coagulation indices in myocardial infarct patients with thromboembolic complications].
    Panchenko VM; Dmitrieva ZA; Pastorova VE
    Ter Arkh; 1971 Aug; 43(8):95-9. PubMed ID: 4261359
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of heparin on blood coagulation and serotonin concentration in patients with coronary atherosclerosis in the pre-infarction state].
    Savel'ev AI
    Vrach Delo; 1972 Nov; 11():14-8. PubMed ID: 4659725
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of endogenous blood heparin levels in normal subjects and in myocardial infarct patients].
    Pavero A; Della Pietra S; Cimmino R
    Boll Soc Ital Cardiol; 1970; 15(2):76-81. PubMed ID: 5494528
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on certain humoral aspects of the preclinical and clinical stage of atherosclerosis in relation to age and sex].
    Enachescu G; David C
    G Gerontol; 1967 Jun; 15(6):695-705. PubMed ID: 4236246
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolytic activity in Behçet's disease].
    Kogure M; Motoji K
    Nippon Ganka Gakkai Zasshi; 1972 Mar; 76(3):114-21. PubMed ID: 4261805
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro thrombosis in acute myocardial infarction.
    Yochem DE; Roach DE
    Ohio State Med J; 1974 Jul; 70(7):419-21. PubMed ID: 4845484
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood fibrinolytic activity in patients following myocardial infarct].
    Myśliwiec M; Bielawiec M; Perzanowski A
    Pol Tyg Lek; 1971 Dec; 26(49):1895-7. PubMed ID: 5156516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the hemostatic system in young persons with primary hyperlipoproteinemia and after myocardial infarction. II. Evaluation of various parameters of the fibrinolytic system].
    Borodin M; Chełstowski ; Jurek D; Pieczul-Mróz J; Gregorczyk J
    Przegl Lek; 1986; 43(11):690-3. PubMed ID: 2953045
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characterization of various streptokinase dosage schedules through quantitative streptokinase, plasminogen and plasmin determinations in the plasma of patients].
    Büchner U; Martin M; Auel H
    Verh Dtsch Ges Inn Med; 1975; 81():1152-5. PubMed ID: 132799
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K; Prokopowicz J; Gabryelewicz A
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Experimental and clinical contribution].
    Panazzolo A; Giambanco V; Pattarelli M; Scarpa F
    Haematol Lat; 1967; 10(4):409-22. PubMed ID: 4232988
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the coagulation and anticoagulation systems of blood in myocardial infarct during the process of treatment with anticoagulants and fibrinolysin].
    Oberemchenko IaV; Atamanchuk NS; Bel'skiĭ NE
    Vrach Delo; 1975 Nov; (11):21-6. PubMed ID: 128203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.